 |
|
Hyponatremia due to Enalapril in an Elderly PatientA Case Report
Hector Gonzalez-Martinez, MD;
James J. Gaspard, MD;
David V. Espino, MD
Arch Fam Med. 1993;2(7):791-793.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Forette F, Handfield-Jones R, Henry-Amar M, et al. Rationale for ACE inhibition in the elderly: treatment of arterial hypertension with enalapril. Gerontology. 1987;33(suppl_1):9-16.
PUBMED
2. Schnaper HW, Stein G, Schoenberger JA, et al. Comparison of enalapril and thiazide diuretics in the elderly hypertensive patient. Gerontology. 1987;33(suppl 1):24-35.
PUBMED
3. Arauz-Pacheco C. Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non—insulin-dependent diabetes receiving sulfonylurea therapy. Am J Med. 1990;89:811-813.
PUBMED
4. Yeo WW, Ramsay LE. Persistent dry cough with enalapril: incidence depends on method used. J Hum Hypertens. 1990;4:517-520.
PUBMED
5. Roberts JR, Wuerz RC. Clinical characteristics of angiotensin-converting enzyme inhibitor-induced angioedema. Ann Emerg Med. 1991;20:555-558.
PUBMED
6. Packer M, Medina N, Yushak M. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure. J Am Coll Cardiol. 1984;3:1035-1043.
ABSTRACT
7. Packer M. Angiotensin converting enzyme inhibitors in chronic heart failure. In: Messerli FH, ed. Cardiovascular Drug Therapy. Philadelphia, Pa: WB Saunders Co; 1990:761-799. 8. Packer M, Lee WH, Medina N, et al. Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med. 1987;106:346-354.
FREE FULL TEXT
9. Packer M, Kessler PD, Gottlieb SS. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management. Postgrad Med J. 1986;62(suppl 1):179-182.
FREE FULL TEXT
10. Sanchez RA, Marco HB, Gilbert P. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension. Drugs. 1985;30(suppl 1):49-58.
PUBMED
11. Biollaz J, Schelling JL, Jacot Des Combs B, et al. Enalapril maleate and a lysine analogue (MK 521) in normal volunteers: relationship between plasma drug levels and renin-angiotensin system. Br J Clin Pharmacol. 1982;14:363-368.
PUBMED
12. Riegger GAJ, Leiban G, Kichsick K. Antidiuretic hormone in congestive heart failure. Am J Med. 1982;72:49-52.
PUBMED
13. Bonjour JP, Malvin RL. Stimulation of ADH release by the renin-angiotensin system. Am J Physiol. 1970;218:1555-1559.
FREE FULL TEXT
14. Johnson AK, Mann JFE, Raascher W, et al. Plasma angiotensin II concentrations and experimentally induced thirst. Am J Physiol. 1981;240:R229-R234.
PUBMED
15. Brunner HR, Waeber B, Nussberger J. Angiotensin converting enzyme inhibitors in arterial hypertension. In: Messerli FH, ed. Cardiovascular Drug Therapy. Philadelphia, Pa: WB Saunders Co; 1990:732-750. 16. Gerber J, Nies AS. Inhibitors of the renin-angiotensin system. In: Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Pergamon Press Inc; 1990:756-762. 17. Gaillard CA, Koomans HA, Mees EJ. Enalapril attenuates natriuresis of atrial natriuretic factor in humans. Hypertension. 1988;11:160-165.
FREE FULL TEXT
18. Weir MR. The effects of enalapril on blood pressure, renal hemodynamics and renal function. Clin Ther. 1989;11:685-700.
PUBMED
19. Galliard CA, Koomans HA, Rabelink TJ, et al. Opposite effects of enalapril and nifedipine on natriuretic response to atrial natriuretic factor: renal function evaluated with clearance studies in humans. Hypertension. 1989;13:173-180.
FREE FULL TEXT
20. Cleland JG, Dargie HJ, McAlpine H, et al. Severe hypotension after first dose of enalapril in heart failure. BMJ. 1985;291:1309-1312.
FREE FULL TEXT
21. Jockings N, Ajayi AA, Reid JL. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat. Br J Clin Pharmacol. 1986;21:341-348.
PUBMED
22. Ajayi AA, Hockings N, Reid JL. Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat. Br J Clin Pharmacol. 1986;21:349-357.
PUBMED
23. Hall JE, Coleman TG, Guyton AC. The renin-angiotensin system: normal physiology and changes in older hypertensives. J Am Geriatr Soc. 1989;37:801-813.
PUBMED
24. Dzau VJ, Swartz SL. Disassociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1987;60:1101-1105.
PUBMED
25. Waeber B, Juillerat-Jeanneret L, Aubert JF, et al. Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors. Br J Clin Pharmacol. 1989;27(suppl 2):175S-180S.
PUBMED
|
